173 related articles for article (PubMed ID: 1588924)
1. Ambenonium is a rapidly reversible noncovalent inhibitor of acetylcholinesterase, with one of the highest known affinities.
Hodge AS; Humphrey DR; Rosenberry TL
Mol Pharmacol; 1992 May; 41(5):937-42. PubMed ID: 1588924
[TBL] [Abstract][Full Text] [Related]
2. Interaction of tetrahydroaminoacridine with acetylcholinesterase and butyrylcholinesterase.
Berman HA; Leonard K
Mol Pharmacol; 1992 Feb; 41(2):412-8. PubMed ID: 1538717
[TBL] [Abstract][Full Text] [Related]
3. Kinetics of inhibition of acetylcholinesterase in the presence of acetonitrile.
Pietsch M; Christian L; Inhester T; Petzold S; Gütschow M
FEBS J; 2009 Apr; 276(8):2292-307. PubMed ID: 19292865
[TBL] [Abstract][Full Text] [Related]
4. Substrate binding to the peripheral site of acetylcholinesterase initiates enzymatic catalysis. Substrate inhibition arises as a secondary effect.
Szegletes T; Mallender WD; Thomas PJ; Rosenberry TL
Biochemistry; 1999 Jan; 38(1):122-33. PubMed ID: 9890890
[TBL] [Abstract][Full Text] [Related]
5. Nonequilibrium analysis alters the mechanistic interpretation of inhibition of acetylcholinesterase by peripheral site ligands.
Szegletes T; Mallender WD; Rosenberry TL
Biochemistry; 1998 Mar; 37(12):4206-16. PubMed ID: 9521743
[TBL] [Abstract][Full Text] [Related]
6. [Interaction of reversible inhibitors with the catalytic centers and allosteric sites of cholinesterases].
Tonkopiĭ VD; Prozorovskiĭ VB; Suslova IM
Biull Eksp Biol Med; 1976 Aug; 82(8):947-50. PubMed ID: 1026294
[TBL] [Abstract][Full Text] [Related]
7. [The effect of pH and reversible inhibitors on decarbamylation of acetylcholinesterase].
Kugusheva LI; Rozengart VI; Sherstobitov OE
Ukr Biokhim Zh (1978); 1991; 63(3):29-35. PubMed ID: 1926583
[TBL] [Abstract][Full Text] [Related]
8. Kinetics of human erythrocyte acetylcholinesterase inhibition by a novel derivative of physostigmine: phenserine.
al-Jafari AA; Kamal MA; Greig NH; Alhomida AS; Perry ER
Biochem Biophys Res Commun; 1998 Jul; 248(1):180-5. PubMed ID: 9675107
[TBL] [Abstract][Full Text] [Related]
9. Role of the peripheral anionic site on acetylcholinesterase: inhibition by substrates and coumarin derivatives.
Radić Z; Reiner E; Taylor P
Mol Pharmacol; 1991 Jan; 39(1):98-104. PubMed ID: 1987454
[TBL] [Abstract][Full Text] [Related]
10. Mercuric chloride effects on the kinetic parameters of human erythrocyte membrane bound acetylcholinesterase.
Aijafari AA
Biochem Mol Biol Int; 1995 Aug; 36(6):1243-53. PubMed ID: 8535296
[TBL] [Abstract][Full Text] [Related]
11. Preparation, in vitro screening and molecular modelling of symmetrical bis-quinolinium cholinesterase inhibitors--implications for early myasthenia gravis treatment.
Komloova M; Musilek K; Horova A; Holas O; Dohnal V; Gunn-Moore F; Kuca K
Bioorg Med Chem Lett; 2011 Apr; 21(8):2505-9. PubMed ID: 21397501
[TBL] [Abstract][Full Text] [Related]
12. [Effect of reversible inhibitors on the reaction capacity of functional portions of the active center of acetylcholinesterase].
Tonkopiĭ VD; Ardab'eva TV
Biull Eksp Biol Med; 1978 Oct; 86(10):441-4. PubMed ID: 708873
[TBL] [Abstract][Full Text] [Related]
13. Unmasking tandem site interaction in human acetylcholinesterase. Substrate activation with a cationic acetanilide substrate.
Johnson JL; Cusack B; Davies MP; Fauq A; Rosenberry TL
Biochemistry; 2003 May; 42(18):5438-52. PubMed ID: 12731886
[TBL] [Abstract][Full Text] [Related]
14. Pharmacodynamic analysis of contractile potentiation by cholinesterase inhibitors in rats.
Yamamoto K; Sawada Y; Iga T
J Pharmacokinet Biopharm; 1996 Aug; 24(4):327-48. PubMed ID: 9044164
[TBL] [Abstract][Full Text] [Related]
15. Self-cancellation of drug properties as a mode of organ selectivity: the antimuscarinic effects of ambenonium.
Kenakin TP; Beek D
J Pharmacol Exp Ther; 1985 Mar; 232(3):732-40. PubMed ID: 2857786
[TBL] [Abstract][Full Text] [Related]
16. Indirect parasympathomimetic activity of metoclopramide: reversible inhibition of cholinesterases from human central nervous system and blood.
Chemnitius JM; Haselmeyer KH; Gonska BD; Kreuzer H; Zech R
Pharmacol Res; 1996; 34(1-2):65-72. PubMed ID: 8981558
[TBL] [Abstract][Full Text] [Related]
17. Differential effects of "peripheral" site ligands on Torpedo and chicken acetylcholinesterase.
Eichler J; Anselment A; Sussman JL; Massoulié J; Silman I
Mol Pharmacol; 1994 Feb; 45(2):335-40. PubMed ID: 8114681
[TBL] [Abstract][Full Text] [Related]
18. Sensitive determination of ambenonium in plasma using inhibitory activity to acetylcholinesterase.
Yamamoto K; Sawada Y; Iga T
Biol Pharm Bull; 1993 Mar; 16(3):280-3. PubMed ID: 8364473
[TBL] [Abstract][Full Text] [Related]
19. Binding of the neurotoxin fasciculin 2 to the acetylcholinesterase peripheral site drastically reduces the association and dissociation rate constants for N-methylacridinium binding to the active site.
Rosenberry TL; Rabl CR; Neumann E
Biochemistry; 1996 Jan; 35(3):685-90. PubMed ID: 8547248
[TBL] [Abstract][Full Text] [Related]
20. Quantitative structure-activity relationships for the pre-steady state acetylcholinesterase inhibition by carbamates.
Lin G; Liao WC; Chan CH; Wu YH; Tsai HJ; Hsieh CW
J Biochem Mol Toxicol; 2004; 18(6):353-60. PubMed ID: 15674842
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
